Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
International Journal of Molecular Sciences|December 17, 2024
Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular CytotoxicityMoritz Bewarder, Konstantinos Christofyllakis, Milena Petersen, et al.
Oncoimmunology|September 20, 2018
Vitamin D deficiency in head and neck cancer patients - prevalence, prognostic value and impact on immune functionFlorian Bochen, Benedikt Balensiefer, Sandrina Körner, et al.
Blood|May 28, 2024
CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo modelsBerit J Brinkmann, Alessia Floerchinger, Christina Schniederjohann, et al.
Intensive Care Medicine Experimental|September 3, 2021
Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019Vadim Lesan, Moritz Bewarder, Carlos Metz, et al.
Yeast (Chichester, England)|July 31, 2010
NY-ESO-1 protein glycosylated by yeast induces enhanced immune responsesAndreas Wadle, Axel Mischo, Sabine Strahl, et al.
Ejhaem|February 23, 2023
Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cellsMaximilian Kiefer, Lorenz Thurner, Theresa Bock, et al.
Nature Reviews. Drug Discovery|September 30, 2025
In vivo chimeric antigen receptor (CAR)-T cell therapyAdrian Bot, Andrew Scharenberg, Kevin Friedman, et al.
Hemasphere|July 15, 2021
The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma CellsMoritz Bewarder, Maximilian Kiefer, Helene Will, et al.
Science Translational Medicine|April 10, 2015
Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphomaHeiko Bruns, Maike Büttner, Mario Fabri, et al.
Cancer Research|May 15, 2015
TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic LeukemiaJumpei Yamazaki, Jaroslav Jelinek, Yue Lu, et al.
Pageof 12